Region:Asia
Author(s):Geetanshi
Product Code:KRAE2121
Pages:82
Published On:February 2026
The Thailand branded generics market is poised for significant growth, driven by increasing healthcare expenditure and a rising prevalence of chronic diseases. As the government continues to enhance healthcare access, particularly in rural areas, the demand for affordable medications will likely surge. Additionally, the integration of digital health solutions and telemedicine is expected to facilitate better patient engagement, further boosting the market. Local manufacturers must adapt to regulatory changes and innovate to remain competitive in this evolving landscape.
| Segment | Sub-Segments |
|---|---|
| By Drug Class | Anti-Hypertensive Anti-Diabetic Oncology Others |
| By Route of Administration | Oral Injectables Topical Others |
| By Therapeutic Area | Cardiovascular Diseases Diabetes Oncology Others |
| By Distribution Channel | Retail Pharmacies Hospital Pharmacies Online Pharmacies Others |
| By Region | Central Thailand Northern Thailand Southern Thailand Northeastern Thailand |
| By Product Formulation | Tablets Capsules Injectables Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Pharmacy Sector Insights | 120 | Pharmacy Owners, Pharmacists |
| Hospital Procurement Practices | 100 | Procurement Managers, Supply Chain Directors |
| Patient Preferences for Branded Generics | 100 | Patients, Caregivers |
| Healthcare Professional Perspectives | 80 | Doctors, Nurses, Healthcare Administrators |
| Market Trends and Regulatory Insights | 70 | Regulatory Affairs Specialists, Industry Analysts |
The Thailand Branded Generics Market is valued at approximately USD 3.6 billion, reflecting significant growth driven by the increasing prevalence of chronic diseases, rising healthcare expenditure, and a growing aging population.